StockData
Natural Alternatives International Inc logo

Natural Alternatives International Inc (NAII) stock

NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.90−0.00 (-0.11%)

Close on Nov 18, 2026Market cap $19.90MP/E –Yield –

Natural Alternatives International r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2026 it was $2.30M, up 27.8% from the year before. Over ten years it grew 7.7% a year on average. The highest annual figure on record is $2.50M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jun 30, 2026$2.30M+27.8%
FY2025Jun 30, 2025$1.80M-5.3%
FY2024Jun 30, 2024$1.90M-9.5%
FY2023Jun 30, 2023$2.10M-16.0%
FY2022Jun 30, 2022$2.50M+31.6%
FY2021Jun 30, 2021$1.90M+5.6%
FY2020Jun 30, 2020$1.80M0.0%
FY2019Jun 30, 2019$1.80M+20.0%
FY2018Jun 30, 2018$1.50M-6.3%
FY2017Jun 30, 2017$1.60M+45.5%
FY2016Jun 30, 2016$1.10M0.0%
FY2015Jun 30, 2015$1.10M+10.0%
FY2014Jun 30, 2014$1.00M-16.7%
FY2013Jun 30, 2013$1.20M+9.1%
FY2012Jun 30, 2012$1.10M+12.2%
FY2011Jun 30, 2011$980.00K–

More Natural Alternatives International figures

See a number that looks wrong?